Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.5 EUR | +0.61% |
|
-0.60% | +96.43% |
03:21pm | Dpa-AFX Overview: COMPANIES from 20/06/2024 - 15:15 | DP |
11:10am | Novartis: towards the filing of a buyout offer for MorphoSys | CF |
Business Summary
Number of employees: 464
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Cancer Medicines
100.0
%
| 278 | 100.0 % | 238 | 100.0 % | -14.37% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
88.8
%
| 0 | 0.0 % | 211 | 88.8 % | - |
Europe (excluding Germany)
11.2
%
| - | - | 27 | 11.2 % | - |
Asia
0.0
%
| - | - | 0 | 0.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Luisa Ciccarelli
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Tim Demuth
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/22/01 |
Julia Neugebauer
IRC | Investor Relations Contact | - | 01/06/01 |
Daniel Palmacci
PRN | Corporate Officer/Principal | - | 01/20/01 |
Ann Merchant
PRN | Corporate Officer/Principal | 59 | 01/18/01 |
Ralf Ostendorp
PRN | Corporate Officer/Principal | - | 01/99/01 |
Corporate Officer/Principal | - | 01/94/01 | |
Klaus de Wall
AUD | Comptroller/Controller/Auditor | - | 01/05/01 |
Corporate Officer/Principal | - | 01/98/01 | |
Human Resources Officer | 54 | 30/12/30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Curran
BRD | Director/Board Member | 56 | 22/19/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,716,423 | 2,130,820 ( 5.650 %) | 53,685 ( 0.1423 %) | 5.650 % |
Company contact information
![address MorphoSys AG(MOR2)](https://cdn.zonebourse.com/static/address/43328105.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.01% | 51.07B | |
-7.54% | 38.78B | |
+35.88% | 38.61B | |
-10.62% | 27.32B | |
+12.17% | 26.35B | |
-17.69% | 19.46B | |
+41.26% | 13.58B | |
+30.25% | 12.46B | |
-3.13% | 11.75B |
- Stock Market
- Equities
- MOR Stock
- MOR2 Stock
- Company MorphoSys AG